Tissue Engineering And Nanotheranostics

(Steven Felgate) #1
b2815 Tissue Engineering and Nanotheranostics “9.61x6.69”

264 Tissue Engineering and Nanotheranostics



  1. Zhang HZ, Li XM, Gao FP, Liu LR, Zhou ZM, Zhang QQ.
    Preparation of folate­modified pullulan acetate nanoparticles for
    tumor­targeted drug delivery. Drug Delivery 17 , 48–57 (2010).

  2. Liu Y, Wang Y, Zhang C, Zhou P, Liu Y, An T, Sun D, Zhang N,
    Wang Y. Core­shell nanoparticles based on pullulan and poly(beta­
    amino) ester for hepatoma­targeted codelivery of gene and chemo­
    therapy agent. ACS. Appl. Mater. Int. 6 , 18712–18720 (2014).

  3. Assanhou AG, Li W, Zhang L, Xue L, Kong L, Sun H, Mo R, Zhang
    C. Reversal of multidrug resistance by co­delivery of paclitaxel and
    lonidamine using a TPGS and hyaluronic acid dual­functionalized lipo­
    some for cancer treatment. Biomaterials 73 , 284–295 (2015).

  4. Choi KM, Kwon IC, Ahn HJ. Self­assembled amphiphilic DNA­
    cholesterol/DNA­peptide hybrid duplexes with liposome­like struc­
    ture for doxorubicin delivery. Biomaterials 34 , 4183–4190 (2013).

  5. Ekdawi SN, Stewart JM, Dunne M, Stapleton S, Mitsakakis N, Dou
    YN, Jaffray DA, Allen C. Spatial and temporal mapping of heterogene­
    ity in liposome uptake and microvascular distribution in an orthotopic
    tumor xenograft model. J. Control. Rel. 207 , 101–111 (2015).

  6. Liu Z, Xiong M, Gong J, Zhang Y, Bai N, Luo Y, Li L, Wei Y, Liu Y,
    Tan X, Xiang R. Legumain protease­activated TAT­liposome cargo for
    targeting tumours and their microenvironment. Nat. Commun. 5 ,
    4280 (2014).

  7. Fan Y, Sahdev P, Ochyl LJ, J JA, Moon JJ. Cationic liposome­hyaluronic
    acid hybrid nanoparticles for intranasal vaccination with subunit anti­
    gens. J. Control. Rel. 208 , 121–129 (2015).

  8. Wu WD, Yi XL, Jiang LX, Li YZ, Gao J, Zeng Y, Yi RD, Dai LP, Li W,
    Ci XY, Si DY, Liu CX. The Targeted­liposome Delivery System of
    Antitumor Drugs. Curr. Drug Metab. 16 , 894–910 (2015).

  9. Namazi H, Adeli M. Dendrimers of citric acid and poly (ethylene gly­
    col) as the new drug­delivery agents. Biomaterials 26 , 1175–1183
    (2005).

  10. Spataro G, Malecaze F, Turrin CO, Soler V, Duhayon C, Elena PP,
    Majoral JP, Caminade AM. Designing dendrimers for ocular drug
    delivery. Eur. J. Med. Chem. 45 , 326–334 (2010).

  11. Dhanikula RS, Hildgen P. Synthesis and evaluation of novel dendrim­
    ers with a hydrophilic interior as nanocarriers for drug delivery.
    Bioconjug. Chem. 17 , 29–41 (2006).

  12. Svenson S. Dendrimers as versatile platform in drug delivery applica­
    tions. Eur. J. Pharm. Biopharm. 71 , 445–462 (2009).

Free download pdf